James L. Kreindler
Vertex Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Cystic Fibrosis Research Advances, Sinusitis and nasal conditions, Allergic Rhinitis and Sensitization, Respiratory and Cough-Related Research
Most-Cited Works
- → IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia(2008)1,143 cited
- → T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection(2012)542 cited
- → Bitter and sweet taste receptors regulate human upper respiratory innate immunity(2014)406 cited
- → Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis(2005)395 cited
- → Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F(2007)353 cited
- → Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial(2021)287 cited
- → Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study(2021)167 cited
- → IL-17RA Is Required for CCL2 Expression, Macrophage Recruitment, and Emphysema in Response to Cigarette Smoke(2011)160 cited
- → Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis(2010)148 cited
- → Cigarette Smoke Exposure Impairs Respiratory Epithelial Ciliogenesis(2009)138 cited